AquaBounty Technologies Inc. (AQB) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. AquaBounty Technologies, Inc. is a biotechnology company focused on the production of genetically engineered (GE) Atlantic salmon (AquAdvantage salmon). The company operates land-based recirculating aquaculture system farms in the U.S. and Canada. As of the reporting date, the company is classified as a "smaller reporting company" and a "non-accelerated filer."
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Product Revenue | $180,182 | $788,430 | $657,450 | $1,186,276 |
| Net Loss | $(50,514,241) | $(6,508,746) | $(61,672,489) | $(12,994,814) |
| Net Loss Per Share (Basic/Diluted) | $(13.08) | $(1.69) | $(16.00) | $(3.38) |
| Cash and Cash Equivalents | $728,339 | $42,842,280 (End of Q2 2023) | $728,339 | $42,842,280 |
| Total Debt (Current + Long-term) | $10,491,518 | $8,544,402 | $10,491,518 | $8,544,402 |
| Assets Held for Sale | $35,086,031 | $0 | $35,086,031 | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 77% in Q2 2024 compared to Q2 2023. This was primarily due to the cessation of GE Atlantic salmon sales as the company wound down operations at its Indiana farm to prepare for sale. The decline was partially offset by increased sales of conventional salmon eggs and fry from the Rollo Bay farm in Canada.
- Significant Impairment Charges: The company recorded a non-cash long-lived asset impairment charge of $44.5 million in Q2 2024 (totaling $48.7 million for the six months). This relates to the Indiana farm and equipment from the Ohio farm being reclassified as "Assets Held for Sale."
- Cash Position: Cash and cash equivalents dropped significantly from $8.2 million at year-end 2023 to $728,339 at June 30, 2024, driven by operating losses and capital expenditures.
- Debt Structure: In April 2024, the company secured a $10 million bridge loan from JMB Capital Partners (15% interest rate) to fund working capital. $5 million was advanced in April, with an additional $1.5 million advanced in July 2024.
Guidance, Outlook, and Risks
- Going Concern Uncertainty: Management has raised substantial doubt about the company's ability to continue as a going concern within one year. The company has incurred cumulative net losses of approximately $282 million and requires additional capital to fund operations.
- Strategic Shifts: Construction of the Ohio farm has been paused. The company is actively selling non-core assets, including the Indiana farm (sale closed July 26, 2024, for net proceeds of $9.2 million) and equipment from the Ohio farm, to generate liquidity.
- Future Revenue: Near-term revenue is expected to consist primarily of conventional Atlantic salmon eggs and fry from Prince Edward Island, as GE salmon production has paused.
- Risk Factors: Key risks include the inability to raise additional capital, high customer concentration (one customer represented 97% of Q2 2024 revenue), regulatory hurdles for GE products, and the impact of inflation on operating costs.
Investor Verification Checklist
- Liquidity Runway: Verify the sufficiency of the $9.2 million proceeds from the Indiana farm sale (closed post-period) combined with remaining cash to fund operations until new financing is secured.
- Asset Sale Execution: Confirm the timeline and expected proceeds from the sale of additional Ohio farm equipment classified as "Assets Held for Sale."
- Debt Covenants: Review the terms of the JMB Capital Partners loan (15% interest, 5% commitment fee, 8% exit fee) and any restrictive covenants that may limit operational flexibility.
- Customer Concentration: Assess the risk associated with 97% of Q2 revenue coming from a single customer (Customer D).
- Ohio Farm Status: Monitor updates on the resumption of construction or alternative financing strategies for the Ohio farm, which is currently paused.